JNJ-70033093

· Janssen Research & Development, LLC

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for JNJ-70033093, covering 2025-03-30 to 2025-03-30. Get the full timeline:

Most recent: Clinical Trial Update: A Study of JNJ-70033093 and Digoxin in Healthy Participants [Phase 1]